More patents and shelf space for Venture Life breath care brand

The AIM-traded firm said the new recent patent grants added to the existing patents already granted in the US, UK, South Africa and New Zealand for the “innovative” product range.

It said it also had patent applications pending in “many other jurisdictions”, including the EU.

The company said the range of products contained a multicomponent composition, and included specific ingredients to “reduce sensitivity” and provide 12 hours of fresh breath.

It said the UltraDEX range of products was manufactured at Venture Life's development facility in Italy.

Domestically, Venture Life said it had also agreed with Boots to list two new additional UltraDEX products, increasing the range of UltraDEX products stocked in store from eight to 10.

As a result of the new listings and further distribution gains, shelf space presence would further increase from July onwards.

The board said it believed that further validated Venture Life's relationship with its “key partner” in the UK, being Boots, and showed the “continuing strength” of the UltraDEX brand.

“In Q1 2017, we ran a second successful UK advertising campaign that saw the UltraDEX brand once again featured on tube cards and radio stations across London and the South East, alongside promotional activity in key retailers,” said CEO Jerry Randall.

“We are planning further activities in 2017 combined with a continued brand refresh and future product development.”

Randall said he was “particularly delighted” to see the further validation of the UltraDEX range in Boots, listing two additional products in the range.

“The progress we are making is testament to our strong leadership team and excellent support network, and reaffirms our strategic direction for the brand that we set out at the time of its acquisition last year.”